J
Josemir W. Sander
Researcher at UCL Institute of Neurology
Publications - 705
Citations - 44517
Josemir W. Sander is an academic researcher from UCL Institute of Neurology. The author has contributed to research in topics: Epilepsy & Population. The author has an hindex of 106, co-authored 680 publications receiving 39038 citations. Previous affiliations of Josemir W. Sander include University of Cincinnati & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Non-randomized open trial of eicosapentaenoic acid (EPA), an omega-3 fatty acid, in ten people with chronic epilepsy.
Alan W.C. Yuen,Alan W.C. Yuen,Dominique Flügel,Annkathrin Poepel,Gail S. Bell,Gail S. Bell,Janet L. Peacock,Josemir W. Sander,Josemir W. Sander +8 more
TL;DR: In this paper, a non-randomized open assessment of eicosapentaenoic acid (EPA) supplementation in ten people (five males) with refractory focal seizures was conducted.
Journal ArticleDOI
Atypical face shape and genomic structural variants in epilepsy
Krishna Chinthapalli,Emanuele Bartolini,Jan Novy,Michael Suttie,Carla Marini,Melania Falchi,Zoe Fox,Lisa M. S. Clayton,Josemir W. Sander,Josemir W. Sander,Renzo Guerrini,Chantal Depondt,Raoul C.M. Hennekam,Peter Hammond,Sanjay M. Sisodiya,Sanjay M. Sisodiya +15 more
TL;DR: Computer-based analysis of 3D face images would detect subtle facial abnormality in people with epilepsy who carry pathogenic structural variants as determined by chromosome microarray and bioinformatics tools are used to explore relationships between facial shape and gene expression within the developing forebrain.
Journal ArticleDOI
European survey of the level of satisfaction of patients and physicians in the management of epilepsy in general practice
TL;DR: Key challenges for the future include improvement in the self-management of epilepsy by patients and more proactive patient-physician interactions and the public's perception of epilepsy so as to remove any associated stigma.
Journal ArticleDOI
Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy
Katri Silvennoinen,Nikola Maria de Lange,Sara Zagaglia,Simona Balestrini,Ganna Androsova,Merel Wassenaar,Pauls Auce,Pauls Auce,Andreja Avbersek,Felicitas Becker,Bianca Berghuis,Ellen Campbell,Antonietta Coppola,Antonietta Coppola,Ben Francis,Stefan Wolking,Gianpiero L. Cavalleri,John Craig,Norman Delanty,Norman Delanty,Marvin Johnson,Bobby P. C. Koeleman,Wolfram S. Kunz,Holger Lerche,Anthony G Marson,Anthony G Marson,Terence J. O'Brien,Josemir W. Sander,Graeme J. Sills,Pasquale Striano,Federico Zara,Job van der Palen,Roland Krause,Chantal Depondt,Sanjay M. Sisodiya +34 more
TL;DR: To study the effectiveness and tolerability of antiepileptic drugs (AEDs) commonly used in juvenile myoclonic epilepsy (JME).
Journal ArticleDOI
Cognitive and mood effects of phenobarbital treatment in people with epilepsy in rural China: a prospective study
Ding Ding,Qing Zhang,Dong Zhou,Weihong Lin,Qingsheng Wu,Jixin Sun,Qianhua Zhao,Peimin Yu,Wenzhi Wang,Jianzhong Wu,Gail S. Bell,Patrick Kwan,Patrick Kwan,Hanneke M. de Boer,Shichuo Li,Pamela J. Thompson,Zhen Hong,Josemir W. Sander +17 more
TL;DR: Phenobarbital was not found to have a major negative impact on cognitive function of people with convulsive seizures and some cognitive gains were observed, possibly due to improved seizure control.